Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta

Biochemical Pharmacology

Volumn 51, Issue 4, 1996, Pages 403-411

  Hakkola, Jukka ^a   Pasanen, Markku ^b   Hukkanen, Janne ^a   Pelkonen, Olavi ^a   Mäenpää, Jukka ^a   Edwards, Robert J ^c   Boobis, Alan R ^c   Raunio, Hannu ^a  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

cytochrome P450; maternal fetal exchange; polymerase chain reaction; smoking

Indexed keywords

7 ETHOXYCOUMARIN DEETHYLASE; AROMATASE; CIGARETTE SMOKE; CYTOCHROME P450 ISOENZYME; ETHOXYRESORUFIN DEETHYLASE; MESSENGER RNA; PROTEIN; UNSPECIFIC MONOOXYGENASE;

ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; PLACENTA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; XENOBIOTIC METABOLISM;

EID: 0030030817     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(95)02184-1     Document Type: Article

References (65)

1. Juchau MR, Drug biotransformation in the placenta. Pharmacol Ther 8: 501-524, 1980.
2. Pasanen M and Pelkonen O, Human placental xenobiotic and steroid biotransformation catalyzed by cytochrome P450 epoxide hydroxylase and glutathione S-transferase activities and their relations to maternal cigarette smoking. Drug Metab Rev 21: 427-446, 1989-1990.
3. Pasanen M and Pelkonen O, The expression and environmental regulation of P450 enzymes in human placenta. Crit Rev Toxicol 24: 211-229, 1994.
4. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O, Okuda K and Nebert DW, The P450 superfamily: update on new sequences gene mapping accession numbers early trivial names of enzymes and nomenclature. DNA Cell Biol 12: 1-51, 1993.
5. Gonzalez FJ, Human cytochromes P450: problems and prospects. Trends Pharm Sci 13: 346-352, 1992.
6. Wrighton SW and Stevens JC, The human hepatic cytochromes P450 involved in the drug metabolism. Crit Rev Toxicol 22: 1-21, 1992.
7. Miles JS and Wolf CR, Developments and perspectives on the role of cytochrome P450s in chemical carcinogenesis. Carcinogenesis 12: 2195-2199, 1991.
8. Beresford AP, CYP1A1: friend or foe. Drug Metab Rev 25: 503-517, 1993.
9. Nebert DW, Drug-metabolizing enzymes in ligand-modulated transcription. Biochem Pharmacol 47: 25-37, 1994.
10. Welch RM, Harrison YE, Gommi BW, Poppers PJ, Finster M and Conney AH, Stimulatory effect of cigarette smoking on the hydroxylation of 3 4-benzpyrene and the N-demethylation of 3-methyl-4-monothylaminoazobenzene by enzymes in the human placenta. Clin Pharmacol Ther 10: 100-109, 1969.
11. Wong TK, Everson RB and Hsu S-T, Potent induction of human placental monooxyganase activity by previous dietary exposure to polyclorinated biphenyls and their thermal degradation products. Lancet I: 721-724, 1985.
12. Pasanen M, Stenbäck F, Park SS, Gelboin HV and Pelkonen O, Immunohistochemical detection of human placental cytochrome P-450-associated mono-oxygenase system induciple by maternal cigarette smoking. Placenta 9: 267-275, 1988.
13. Pasanen M, Haaparanta T, Sundin M, Sivonen P, Vähakangas K, Raunio H, Hines R, Gustafsson J-Å and Pelkonen O, Immunochemical and molecular biological studies on human placental cigarette smoke-induciple cytochrome P-450-dependent monooxygenase activities. Toxicology 62: 175-187, 1990.
14. Pelkonen O, Fetoplacental biochemistry - xenobiotic metabolism and pharmacokinetics. In: Occupational Hazards and Reproduction (Eds. Hemminki K, Sorsa M and Vainio H), pp. 113-126. Hemisphere, Washington, DC, 1985.
15. Schuetz JD, Kauma S and Guzelian PS, Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta. J Clin Invest 92: 1018-1024, 1993.
16. Yokotani N, Sogawa K, Matsubara S, Gotoh O, Kusunose M and Fujii-Kuriyama Y, cDNA cloning of cytochrome P-450 related to P-450p-2 from the cDNA library of human placenta, genestructure and expression. Eur J Biochem 187: 23-29, 1990.
17. Foley KP, Leonard MW and Engel JD, Quantitation of RNA using the polymerase chain reaction. Trends Genet 9: 380-385, 1993.
18. Devereux J, Haeberli P and Smithies O, A comprehensive set of sequence analysis preograms for VAX and convex systems. Nucleic Acids Res 12: 387-395, 1984.
19. 1-450: complementary DNA and amino acid sequence. Science 228: 80-83, 1985.
20. 3450 cDNA and complete amino acid sequence. Nucleic Acids Res 14: 6773-6774, 1986.
21. Yamano S, Tatsuno J and Gonzalez FJ, The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry 29: 1322-1329, 1990.
22. Yamano S, Nhamburo PT, Aoyama T, Meyer UA, Inaba T, Kalow W, Gelboin HV, McBride OW and Gonzalez FJ, cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derivated from the CYP2B locus on chromosome 19 and differential expression of the IIB mRN As in human liver. Biochemistry 28: 7340-7348, 1989.
23. Kimura S, Pastewka J, Gelboin HV and Gonzalez FJ, cDNA and amino acid sequences of two members of human P450IIC gene subfamily. Nucleic Acids Res 15: 10053-10054, 1987.
24. Romkes M, Faletto MB, Blaisdell JA, Raycy JL and Goldstein JA, Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450I1C subfamily. Biochemistry 30: 3247-3255, 1991.
25. Kimura S, Umeno M, Skoda RC, Meyer UA and Gonzalez FJ, The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene a related gene and a pseudogene. Am J Hum Genet 45: 889-904, 1989.
26. Song B-J, Gelboin HV, Park SS, Yang CS and Gonzalez FJ, Complementary DNA and Protein sequences of ethanol-inducible rat and human cytochrome P-450s. J Biol Chem 35: 16689-16697, 1986.
27. Nhamburo PT, Kimura S, McBride OW, Kozak CA, Gelboin HV and Gonzalez FJ, The human CYP2F gene subfamily: identification of a cDNA encoding a new cytochrome P450 cDNA-directed expression and chromosome mapping. Biochemistry 29: 5491-5499, 1990.
28. Molowa DT, Schuetz EG, Wrighton SA, Watkins PB, Kremers P, Mendez-Picon G, Parker GA and Guzelian PS, Complete cDNA sequence of a cytochrome P-450 induciple by glucocorticoids in human liver. Proc Natl Acad Sci USA 83: 5311-5315, 1986.
29. Gonzalez FJ, Schmid BJ, Umeno M, McBride OW, Hardwick JP, Meyer UA, Gelboin HV and Idle JR, Human P450PCN1: sequence chromosome localization and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase. DNA 7: 79-86, 1988.
30. Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV and Gonzalez FJ, Cytochrome P-450 hPCN3 a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. J Biol Chem 264: 10388-10395, 1989.
31. Komori M, Nishio K, Ohi H, Kitada M and Katamaki T, Molecular cloning and sequence analysis of cDNA containing the entire coding region for human fetal liver cytochrome P-450. J Biochem 105: 161-163, 1989.
32. Nhamburo PT, Gonzalez FJ, McBride OW, Gelboin HV and Kimura S, Identification of a new P450 expressed in human lung: complete cDNA sequence cDNA-directed expression and chromosome mapping. Biochemistry 28: 8060-8066, 1989.
33. Pelkonen O and Pasanen M, Effect of heparin on the subcellular distribution of human placental 7-ethoxycoumarin O-deethylase activity. Biochem Pharmocol 30: 3254-3256, 1981.
34. Nebert DW and Gelboin HV, Substrate-indicible microsomal aryl hydroxylase in mammalian cell culture. I. Assay and properties of induced enzyme. J Biol Chem 243: 6242-6249, 1968.
35. Aitio A, A simple and sensitive assay of 7-ethoxycoumarin deethylation. Anal Biochem 85: 488-491, 1978.
36. Burke MD, Prough RA and Mayer RT, Characteristics of a microsomal cytochrome P-448-mediated reaction: ethoxyresorufin O-deethylation. Drug Metab Disp 5: 1-8, 1977.
37. 18 reverse-phased cartridge for separation of tritiated water or steroid metabolites in placentas from both smoking and non-smoking mothers in vitro. Biol Res Pregn 6: 94-99, 1985.
38. Waxman DJ, Ko A and Walsh C, Radioselectivity and stereoselectivity of androgen hydroxylations catalysed by cytochrome P-450 isozymes purified from phenobarbital induced rat liver. J Biol Chem 258: 11937-11947, 1983.
39. Pasanen M and Pelkonen O, Cholesterol side-chain cleavage activity in human placenta and bovine adrenals: a one-step method for separation of pregnenolone in vitro. Steroids 43: 517-525, 1984.
40. Cochin J and Axelrod J, Biochemical and pharmacological changes in the rat following chronic administration of morphine nalorphine and normorphine. J Pharmacol Exp Ther 125: 105-110, 1959.
41. Nash T, The calorimetric estimation of formaldehyde by means of the Hantzoch reaction. Biochem J 55: 416-421, 1953.
42. Peter R, Böcker R, Beaune BH, Iwasaki M, Guengerich FP and Yang CS, Hydroxylation and chlorozoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem Res Toxicol 3: 566-573, 1990.
43. Edwards RJ, Singleton AM, Murray BP, Davies DS and Boobis AR, Short synthetic peptides exploited for reliable and spesific targeting of antibodies to the C-termini of cytochrome P450 enzymes. Biochem Pharmacol 49: 39-47, 1995.
44. Edwards RJ, Singleton AM, Sesardic D, Boobis AR and Davies DS, Antibodies to a synthetic peptide that react specifically with a common surface region on two hydrocarbon-inducible isoenzymes of cytochrome P-450 in the rat. Biochem Pharmacol 37: 3735-3741, 1988.
45. Murray BP, Edwards RJ, Murray S, Singleton AM, Davies DS and Boobis AR, Human hepatic CYP1A1 and CYP1A2 content determined with specific anti-peptide antibodies, correlates with the mutagenic activation of PhIP. Carcinogenesis 14: 585-592, 1993.
46. Laemmli UK, Cleavage of structural proteins during the assembly of the head of bacteriophage Y4. Nature 227: 680-685, 1970.
47. Towbin H, Staehelin T and Gordon J, Electroforetic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979.
48. Edwards RJ, Murray BP, Murray S, Schulz T, Neubert D, Gant TW, Thorgeirsson SS, Boobis AR and Davies DS, Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human. Carcinogenesis 15: 829-836, 1994.
49. Ching MS, Lennard MS, Tucker GT, Woods HF, Kelly DE and Kelly SL, The expression of human cytochrome P450IA1 in the yeast Saccharomyces cerevisiae. Biochem Pharmacol 42: 753-758, 1991.
50. Greenlee WF and Poland A, An improved assay of 7-ethoxy-coumarin O-deethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital 3-methylcholantherene and 2378-tetrachloro-p-dioxin. J Pharmacol Exp Ther 205: 596-605, 1978.
51. Kitawaki J, Inoue S, Tamura T, Yamamoto T, Honjo H, Higashiyama T, Osawa Y and Okada H, Cigarette smoking during pregnancy lowers aromatase cytochrome P-450 in the human placenta. J Steroid Biochem Molec Biol 45: 485-491, 1993.
52. Waxman DJ, Lapenson DP, Aoyama T, Gelboin HV, Gonzalez FJ and Korzekwa K, Steroid hormone hydroxylase specifities of eleven cDNA-expressed human cytochrome P450s. Arch Biochem Biophys 290: 160-166, 1991.
53. Sesardic D, Pasanen M, Pelkonen O and Boobis AR, Differential expression and regulation of members of the cytochrome P450IA gene subfamily in human tissues. Carcinogenesis 11: 1183-1188, 1990.
54. Manchester DK, Gordon SK, Golas CL, Roberts EA and Okey AB, Ah receptor in human placenta: stabilization by molybdate and characterization of binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin 3-methylcholantherene and benzo(a)pyrene. Cancer Res 47: 4861-4868, 1987.
55. Dolwick KM, Schmidt JV, Carver LA, Swanson HI and Bradfield CA, Cloning and expression of a human Ah receptor cDNA. Molec Pharmacol 44: 911-917, 1993.
56. Schmidt JV, Carver LA and Bradfield CA, Molecular characterization of the murine Ahr gene. J Biol Chem 268: 22203-22209, 1993.
57. Wheeler CW, Wrighton SA and Guenthner TM, Detection of human lung cytochromes P450 that are immunochemically related to cytochrome P450IIE1 and cytochrome P450IIIA. Biochem Pharmacol 44: 183-186, 1992.
58. Song B-J, Veech RL and Saenger P, Cytochrome P450IIE1 is elevated in lymphocytes from poorly controlled insulin-dependent diabetics. Clin Endocrinol Metab 71: 1036-1040, 1990.
59. Farin FM, Pohlman TH and Omiecinski CJ, Expression of cytochrome P450s and microsomal epoxide hydrolase in primary cultures of human umbilical vein endothelial cells. Toxicol Appl Pharmacol 124: 1-9, 1994.
60. Song BJ, Veech RL, Park SS, Gelboin HV and Gonzalez FJ, Induction of rat hepatic N-nitrosodimethylamine demethylase by acetone is due to protein stabilization. J Biol Chem 264: 3568-3572, 1989.
61. Jones SM, Boobis AR, Moore GE and Stanier PM, Expression of CYP2E1 during human fetal delelopment: methylation of the CYP2E1 gene in human fetal and adult liver samples. Biochem Pharmacol 43: 1876-1879, 1992.
62. Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kato R and Kanakubo Y, Purification and properties of cytochrome P-450 from homogenates of human fetal livers. Arch Biochem Biophys 241: 275-280, 1985.
63. Schuetz JD, Beach DL and Guzelian PS, Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 4: 11-20, 1994.
64. Hakkola J, Pasanen M, Purkunen R, Saarikoski S, Pelkonen O, Mäenpää J, Rane A and Raunio H, Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem Pharmacol 48: 59-64, 1994.
65. Gonzalez FJ, The molecular biology of cytochrome P450s. Pharmacol Rev 40: 243-288, 1989.